Anti-bacterial and Anti-viral Plaque reduction assay (Co-, pre-and post-exposure antiviral activity), qRT-PCR. Inhibitory activity against viral hemorrhagic septicemia virus (VHSV) in the fathead minnow (FHM) cell line. Significantly induced inflammatory cytokine responses (interleukin (IL)-1β, IL-6, and IFN-γ) and interferon (IFN)-α/β, interferon stimulated gene (ISG) 15 and Mx were significantly activated. In vitro/ In vivo [67] Severe acute respiratory syndrome coronavirus 3C-like proteinase (SARS-CoV 3CL pro ) cis-cleavage assay. Inhibition through SARS-CoV 3CL pro trans/cis-cleavage. In vitro [68] Anti-inflammatory The flux of albumin in a dual chamber system monitored in lipopolysaccharide (LPS)-mediated human umbilical vein endothelial cells (HUVECs) and in mice. Acetic acid-induced vascular permeability in mice. Inhibited LPS-mediated barrier disruption and trans endothelial migration of leukocytes to human endothelial cells. Suppressed acetic acid induced-hyper permeability and carboxymethylcellulose-induced leukocytes migration in vivo. In vitro/ In vivo [69] Competitive ELISA for high mobility group box 1 (HMGB1), permeability assay in vitro and in vivo, cell-cell adhesion assay, migration assay in vitro and in vivo. In vitro/ In vivo [24] Assays of mouse ear edema induced by arachidonate (AA), 12-O-tetradecanoylphorbol-13-acetate (TPA), and oxazolone (OXA). Cell stimulation, anti-degranulation assay and qRT-PCR Suppressed mouse ear swelling and the release of histamine, leukotriene B 4 , prostaglandin E 2 , and mRNA expression, and/or the activity of COX-2 in rat basophilic leukemia (RBL)-2H3 cells, inhibited delayed-type (type IV) allergic reactions induced by oxazolone In vivo [70] RNA extraction, RT-PCR, Western blot analysis Inhibited the expression and production of proinflammatory mediators and cytokines in HaCat cells. Inhibited phosphorylation of Akt and activation of NF-κb mediated by Propionibacterium acnes. In vitro [71] Secretory phospholipase A 2 s, soybean lipoxygenase (LOX), 5-lipoxygenase, and COX-1 and COX-2 inhibitory assay. Inhibition on secretory phospholipase A 2 s, LOX and COX activity. In vitro [72] Anti-histamine Histamine release assay. Rat basophilic leukemia (RBL)-2H3 cell stimulation and assay for β-hexosaminidase release. Flow cytometry analysis. Inhibition on the degranulation of KU812 cells stimulated by immunoglobulin E (IgE) and anti-IgE antibodies. Inhibition on the degranulation of RBL-2H3 cells mediated by IgE stimulation via a granular enzyme (β-hexosaminidase). Inhibited binding of IgE and FcεRI receptor in KU812 cells. In vitro [73] Assay of hyaluronidase. Showed inhibition in hyaluronidase activity. In vitro [74] Anti-hypertensive Angiotensin converting enzyme (ACE) inhibitory activity assay. Determination of nitric oxide (NO) production. ACE inhibitory and peroxynitrite scavenging properties. In vitro [28] Anti-cancer Flow cytometric analysis, soft agar colony formation assay, and invasion assay. PI3K kinase assay, Raf-1 kinase assay, and activated Ras affinity precipitation assay. Suppressed expression of the glioma stem-like cell markers and the self-renewal-related proteins without cell death. Inhibited PI3K-Akt and Ras-Raf-1-Erk signaling pathways. In vitro [75] MTT reduction assay on a limited variety of cancer cell lines. Exhibited anti-proliferation effect. In vitro [76]  


Section:pharmacological effect experimental methods pathway/mode application references